Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LETROZOLE\RIBOCICLIB vs LEVOBUNOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LETROZOLE\RIBOCICLIB vs LEVOBUNOLOL: Safety Overview

Metric LETROZOLE\RIBOCICLIB LEVOBUNOLOL
Total FAERS Reports 621 144
Deaths Reported 78 2
Death Rate 12.6% 1.4%
Hospitalizations 80 7
Average Patient Age 64.2 yrs 76.5 yrs
% Female Patients 98.2% 65.8%
FDA Approval Date N/A Aug 3, 2000
Manufacturer N/A Bausch & Lomb Incorporated
Route N/A OPHTHALMIC
Marketing Status N/A Prescription